论文部分内容阅读
（目的〕探索非小细胞肺癌的化疗方式。〔方法）对30例病人采用三苯氧胺、异博定加MFP方案（甲组）化疗，并随机与采用CAP或IEP方案（乙组）的30例病人进行比较。［结果〕两级总有效率分别为43.3％和26．7％；甲级毒副反应轻微，生活质量明显改各，一年生存率提高，统计学处理差异有显著性（P＜0．05）、〔结论）使用三苯氧胺、异搏定加MFP方案治疗非小细胞肺癌具有临床探讨价值。
(Objective) To explore the chemotherapy for non-small-cell lung cancer.Methods Thirty patients were treated with tamoxifen, ibromide plus MFP regimen (group A) and 30 patients with CAP or IEP regimen (group B). Compare. [Results] The total effective rates of the two grades were 43.3% and 26.7% respectively. The grade A toxicity was mild, and the quality of life was significantly improved. The one-year survival rate was improved, and there was a statistically significant difference (P<0.05). ), [Conclusion] The use of tamoxifen, verapamil plus MFP regimen in the treatment of non-small cell lung cancer has clinical value.